Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I-II Prospective Trial, Multicenter, Open Label, Exploring the Combination of Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma Patients

NCT02275286 is registered in ClinicalTrials.gov with Grupo Espanol de Investigacion en Sarcomas as lead sponsor.

NCT NCT02275286
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02275286 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I-II Prospective Trial, Multicenter, Open Label, Exploring the Combination of Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma Patients
Lead sponsor
Grupo Espanol de Investigacion en Sarcomas
Phase
Phase 1/2
Overall status
Recruiting
Start date
November 30, 2014
Completion date
June 30, 2028
Enrollment
199 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

leiomyosarcoma, liposarcoma, liposarcoma, myxoid, pleomorphic liposarcoma, sarcoma, soft tissue